Retraction: A nomogram for predicting metabolic-associated fatty liver disease in non-obese newly diagnosed type 2 diabetes patients

• July 20, 2026

Can Patients Switch to Biosimilar Aflibercept?

A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.

• by Andrea Surnit

• July 20, 2026

• 3 min

Correction: Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis

• by Asad Omarion, Yaman Ayasa, Zainab Omarion, Batoul Jayouse, Hazem Ayesh

• July 20, 2026

Integrated cardiac, endocrine, and genetic assessment in adolescent basketball players

• by Katerina Gregorova, Lukas Plachy, Vaclav Chaloupecky, Olena Iurchenko, Klara Maliska Maratova, Aneta Kodytkova, Martin Matoulek, Jan Lebl, Viktor Tomek, Zdenek Sumnik, Petra Dusatkova, Stepanka Pruhova

• July 20, 2026